|
| 37743815 | Prescribing cascades in ambulatory care: A structured synthesis of evidence. | Pharmacotherapy | 2024 |
| 36286487 | Incidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort study. | Allergy | 2023 |
| 37058293 | Estimated Use of Prescription Medications Among Individuals Incarcerated in Jails and State Prisons in the US. | JAMA Health Forum | 2023 |
| 37205340 | Effect of Nirmatrelvir/Ritonavir (Paxlovid) on Hospitalization among Adults with COVID-19: an EHR-based Target Trial Emulation from N3C. | medRxiv | 2023 |
| 37329956 | Real-world utilization of Arachis hypogaea for peanut allergy: Patient and provider perspective. | J Allergy Clin Immunol Pract | 2023 |
| 37094897 | Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis. | BMJ Open | 2023 |
| 37064694 | COVID-19 unemployment and access to statin medications in the United States. | Front Public Health | 2023 |
| 37261447 | Single and combined use of fall-risk-increasing drugs and fracture risk: a population-based case-control study. | Age Ageing | 2023 |
| 36723359 | Inclusion of Participants with CKD and Other Kidney-Related Considerations during Clinical Drug Development: Landscape Analysis of Anticancer Agents Approved from 2015 to 2019. | Clin J Am Soc Nephrol | 2023 |
| 36749334 | Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer Advertising. | JAMA | 2023 |
| 36400263 | Noninterventional studies in the COVID-19 era: methodological considerations for study design and analysis. | J Clin Epidemiol | 2023 |
| 36740144 | Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: AÂ target trial emulation. | J Allergy Clin Immunol | 2023 |
| 36538979 | Comparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis. | J Allergy Clin Immunol | 2023 |
| 36571281 | Changes in anticoagulant and antiplatelet drug supply at US hospitals before and during the COVID-19 pandemic (2018-2021). | Am J Health Syst Pharm | 2023 |
| 36630560 | Discontinuation of Buprenorphine Treatment for Opioid Use Disorder During the Coronavirus Disease-2019 Pandemic: A Multilevel Framework. | Med Care | 2023 |
| 34590369 | Effect of reductions in opioid prescribing on opioid use disorder and fatal overdose in the United States: a dynamic Markov model. | Addiction | 2022 |
| 35772597 | Comparative efficacy of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: AÂ Bayesian network meta-analysis. | J Allergy Clin Immunol | 2022 |
| 35475341 | National Trends in Use of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020. | J Am Heart Assoc | 2022 |
| 35404287 | Making the Case for Accelerated Withdrawal of Aducanumab. | J Alzheimers Dis | 2022 |
| 35343584 | Reply to: The informed majority could help make research into Alzheimer's disease fairer and more efficient. | J Am Geriatr Soc | 2022 |
| 35500949 | Cost-Effectiveness of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer: An Economic Evaluation Based on Network Meta-Analysis. | Value Health | 2022 |
| 35467448 | Health care utilization and costs of systemic lupus erythematosus in the United States: A systematic review. | Lupus | 2022 |
| 35665948 | Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review. | Pharmacotherapy | 2022 |
| 35569118 | Use of prescription medications with cardiovascular adverse effects among older adults in the United States. | Pharmacoepidemiol Drug Saf | 2022 |
| 35364622 | Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010-2016. | Pharmacotherapy | 2022 |
| 35852888 | Medicare Advantage coverage restrictions for the costliest physician-administered drugs. | Am J Manag Care | 2022 |
| 35595609 | Treatment of Opioid Use Disorder With Buprenorphine Among US Adolescents and Young Adults During the Early COVID-19 Pandemic. | J Adolesc Health | 2022 |
| 35658522 | COVID-19 vaccine hesitancy among rural Oklahomans. | Rural Remote Health | 2022 |
| 36581417 | Drug-drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case-control study in the National COVID Cohort Collaborative (N3C). | BMJ Open | 2022 |
| 36453260 | Comparative Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin Among Adults With Cancer and Atrial Fibrillation. | Circ Cardiovasc Qual Outcomes | 2022 |
| 36306147 | Distribution of Abatement Funds Arising From US Opioid Litigation. | JAMA | 2022 |
| 36095314 | Development and Validation of the Summary Elixhauser Comorbidity Score for Use With ICD-10-CM-Coded Data Among Older Adults. | Ann Intern Med | 2022 |
| 36395143 | Diabetes medications and associations with Covid-19 outcomes in the N3C database: A national retrospective cohort study. | PLoS One | 2022 |
| 36282149 | Pharmacologic Treatment of Type 2 Diabetes in the U.S., Sweden, and Israel. | Diabetes Care | 2022 |
| 33830214 | Comparison of Treatments for Nonmetastatic Castration-Resistant Prostate Cancer: Matching-Adjusted Indirect Comparison and Network Meta-Analysis. | J Natl Cancer Inst | 2022 |
| 35319522 | Rejection of Aducanumab (Aduhelm) by the Health Care Community: Lessons Learned and the Path Ahead. | Med Care | 2022 |
| 35254434 | Utilization of Filgrastim and Infliximab Biosimilar Products in Medicare Part D, 2015-2019. | JAMA Netw Open | 2022 |
| 35129210 | Public opinion regarding U.S. Food and Drug Administration approval of aducanumab and potential policy responses: A nationally representative survey. | J Am Geriatr Soc | 2022 |
| 35286141 | Effects of State Opioid Prescribing Laws on Use of Opioid and Other Pain Treatments Among Commercially Insured U.S. Adults. | Ann Intern Med | 2022 |
| 35248573 | Predictors of new persistent opioid use after benign hysterectomy in the United States. | Am J Obstet Gynecol | 2022 |
| 34910128 | Real-World Effectiveness of Remdesivir in Adults Hospitalized With Coronavirus Disease 2019 (COVID-19): A Retrospective, Multicenter Comparative Effectiveness Study. | Clin Infect Dis | 2022 |
| 35139298 | Association of opioid utilization management with prescribing and overdose. | Am J Manag Care | 2022 |
| 34965990 | Author Response: Risk of Hospitalization and Death Associated With Pimavanserin Use in Older Adults With Parkinson Disease. | Neurology | 2022 |
| 32838675 | Association of Pharmaceutical Industry Payments to Physicians With Prescription and Medicare Expenditures for Pimavanserin. | Psychiatr Serv | 2021 |
| 35977211 | Changes in Short-term, Long-term, and Preventive Care Delivery in US Office-Based and Telemedicine Visits During the COVID-19 Pandemic. | JAMA Health Forum | 2021 |
| 35977193 | Factors Associated With Manufacturer Drug Coupon Use at US Pharmacies. | JAMA Health Forum | 2021 |
| 33830229 | Quality of Preventive and Chronic Illness Care for Insured Adults With Opioid Use Disorder. | JAMA Netw Open | 2021 |
| 33881795 | Ambulatory noninsulin treatment of type 2 diabetes mellitus in the United States, 2015 to 2019. | Diabetes Obes Metab | 2021 |
| 33622271 | High-dose opioid utilization and mortality among individuals initiating hemodialysis. | BMC Nephrol | 2021 |
| 33760094 | Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19. | JAMA Netw Open | 2021 |